HCA Healthcare, Inc. $HCA Shares Purchased by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 154.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 4,693 shares of the company’s stock after acquiring an additional 2,849 shares during the quarter. Hudson Bay Capital Management LP’s holdings in HCA Healthcare were worth $2,000,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Sovran Advisors LLC increased its stake in HCA Healthcare by 1.0% during the 3rd quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after buying an additional 22 shares in the last quarter. Centerpoint Advisors LLC increased its position in shares of HCA Healthcare by 11.0% during the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after purchasing an additional 22 shares in the last quarter. Cary Street Partners Financial LLC lifted its holdings in HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after purchasing an additional 22 shares in the last quarter. Angeles Wealth Management LLC grew its holdings in shares of HCA Healthcare by 2.4% during the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock worth $432,000 after buying an additional 24 shares in the last quarter. Finally, One Capital Management LLC lifted its stake in shares of HCA Healthcare by 1.1% in the third quarter. One Capital Management LLC now owns 2,250 shares of the company’s stock worth $959,000 after buying an additional 24 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Jim Cramer publicly recommended buying HCA, calling it a buy in “big clumps,” which can drive retail interest and short‑term inflows. Jim Cramer on HCA Healthcare
• Positive Sentiment: HCA hospitals received regional/national recognition (Ocala hospitals praised for patient safety; HCA Florida North Florida Hospital named to America’s 250 Best Hospitals), which supports brand, referrals and patient volumes. Ocala hospitals honored for excellence in patient safety
• Positive Sentiment: HCA Florida North Florida Hospital included among America’s 250 Best Hospitals, reinforcing quality credentials that can protect pricing and payer relationships. HCA Florida North Florida Hospital among America’s 250 Best Hospitals
• Positive Sentiment: Virginia regulators approved new hospitals/expansions that include HCA projects, supporting medium‑term revenue growth and market share in that region. State approves three Chesterfield hospital projects
• Neutral Sentiment: Human-interest coverage (a North Carolina NICU St. Patrick’s Day feature) highlights community care but is unlikely to move the stock materially. North Carolina NICU Celebrates St. Patrick’s Day
• Negative Sentiment: HCA’s board urged shareholders to reject a proposal for fuller reporting on the aftermath of the 2019 Mission sale — a governance/oversight flashpoint that can raise investor concern and activist interest. HCA board urges shareholders to reject proposal
• Negative Sentiment: An HCA hospital CEO is leaving for Beth Israel Lahey Health — an executive departure that may be seen as local leadership turnover and could modestly concern investors about continuity in affected markets. HCA hospital CEO heads to Beth Israel Lahey Health

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 15,214 shares of company stock valued at $7,797,595. Corporate insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. The Goldman Sachs Group lifted their price objective on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a research note on Monday, December 15th. Mizuho boosted their price target on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Finally, Royal Bank Of Canada lifted their target price on shares of HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $537.73.

HCA Healthcare Trading Down 1.2%

Shares of NYSE:HCA opened at $493.61 on Friday. The business has a 50-day moving average price of $510.01 and a 200 day moving average price of $473.55. HCA Healthcare, Inc. has a 12-month low of $314.43 and a 12-month high of $556.52. The company has a market capitalization of $110.36 billion, a price-to-earnings ratio of 17.39, a PEG ratio of 1.52 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. HCA Healthcare’s revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s payout ratio is currently 10.99%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.